[Federal Register Volume 75, Number 15 (Monday, January 25, 2010)]
[Notices]
[Pages 3911-3912]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-1274]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC), 
announces the following meeting of the aforementioned committee:

Board Public Meeting Times and Dates (All Times Are Pacific Standard 
Time)

8:45 a.m.-4:30 p.m., February 9, 2010.
9 a.m.-6 p.m., February 10, 2010.
9 a.m.-3 p.m., February 11, 2010.

Public Comment Times and Dates (All Times Are Pacific Standard Time)

4:30 p.m.-6 p.m., February 9, 2010.*
6 p.m.-7:30 p.m., February 10, 2010.*

    *Please note that the public comment periods may end before the 
times indicated, following the last call for comments. Members of the 
public who wish to provide public comment should plan to attend public 
comment sessions at the start times listed.
    Place: Marriott Manhattan Beach, 1400 Parkview Avenue, Manhattan 
Beach, California; Phone: (310) 546-7511; Fax: (310) 939-1486. Audio 
Conference Call via FTS Conferencing. The USA toll free dial-in number 
is 1-866-659-0537 with a pass code of 9933701.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 100 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program (EEOICP) Act of 
2000 to advise the President on a variety of policy and technical 
functions required to implement and effectively manage the new 
compensation program. Key functions of the Advisory Board include 
providing advice on the development of probability of causation 
guidelines which have been promulgated by the Department of Health and 
Human Services (HHS) as a final rule, advice on methods of dose 
reconstruction which have also been promulgated by HHS as a final rule, 
advice on the scientific validity and quality of dose estimation and 
reconstruction efforts being performed for purposes of the compensation 
program, and advice on petitions to add classes of workers to the 
Special Exposure Cohort (SEC).
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2011.
    Purpose: This Advisory Board is charged with (a) Providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advise the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters To Be Discussed: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update and Program Evaluation Plans; Department 
of Labor (DOL) Program Update; Department of Energy (DOE) Program 
Update; OCAS Science Update; Special Exposure Cohort (SEC) petitions 
for: Lawrence Livermore National Laboratory, Santa Susana Area IV, 
Canoga Avenue Facility (Los Angeles County, California), Lawrence 
Berkeley National Laboratory, General Electric Company (Evendale, 
Ohio), Blockson Chemical Company, Chapman Valve Manufacturing Company, 
United Nuclear Corporation (Hematite, Missouri), Hanger 481 at Kirtland 
Air Force Base, Nevada Test Site, and Westinghouse Electric 
Corportation (Bloomfield, New Jersey); SEC Petition Status Updates; 
Subcommittee and Work Group Reports; Board Working Time; and Conflict 
of Interest Requirements.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted in accordance with the redaction policy provided below. Any 
written comments received will be provided at the meeting and should be 
submitted to the contact person below well in advance of the meeting.
    Policy on Redaction of Board Meeting Transcripts (Public Comment), 
(1) If a person making a comment gives his or her name, no attempt will 
be made to redact that name. (2) NIOSH will take reasonable steps to 
ensure that individuals making public comment are aware of the fact 
that their comments (including their name, if provided) will appear in 
a transcript of the meeting posted on a public Web site. Such 
reasonable steps include: (a) A statement read at the start of each 
public comment period stating that transcripts will be posted and names 
of speakers will not be redacted; (b) A printed copy of the statement 
mentioned in (a) above will be displayed on the table where individuals 
sign up to make public comment; (c) A statement such as outlined in (a) 
above will also appear with the agenda for a Board Meeting when it is 
posted on the NIOSH Web site; (d) A statement such as in (a) above will 
appear in the Federal Register Notice that announces Board and 
Subcommittee meetings. (3) If an individual, in making a statement, 
reveals personal information (e.g., medical information) about 
themselves, that information will not usually be redacted. The NIOSH 
FOIA coordinator will, however, review such revelations in accordance 
with the Freedom of Information Act and the Federal Advisory Committee 
Act and if deemed appropriate, will redact such information. (4) All 
disclosures of information concerning third parties will be redacted. 
(5) If it comes to the attention of the DFO that an individual wishes 
to share information with the Board but objects to doing so in a public 
forum, the DFO will work with that individual, in accordance with the 
Federal Advisory Committee Act, to find a way that the Board can hear 
such comments.
    Contact Person for More Information: Theodore Katz, M.P.A., 
Executive Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta, 
GA 30333, Telephone (513) 533-6800, Toll Free 1(800) CDC-INFO, E-mail 
ocas@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.


[[Page 3912]]


    Dated: January 14, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-1274 Filed 1-22-10; 8:45 am]
BILLING CODE 4163-18-P